CN104840775A - Traditional Chinese medicine for treating vitiligo - Google Patents

Traditional Chinese medicine for treating vitiligo Download PDF

Info

Publication number
CN104840775A
CN104840775A CN201510284958.2A CN201510284958A CN104840775A CN 104840775 A CN104840775 A CN 104840775A CN 201510284958 A CN201510284958 A CN 201510284958A CN 104840775 A CN104840775 A CN 104840775A
Authority
CN
China
Prior art keywords
parts
chinese medicine
fructus
radix
traditional chinese
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510284958.2A
Other languages
Chinese (zh)
Inventor
万家林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hefei Fengruilong Biological Technology Co Ltd
Original Assignee
Hefei Fengruilong Biological Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hefei Fengruilong Biological Technology Co Ltd filed Critical Hefei Fengruilong Biological Technology Co Ltd
Priority to CN201510284958.2A priority Critical patent/CN104840775A/en
Publication of CN104840775A publication Critical patent/CN104840775A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicine for treating vitiligo. The traditional Chinese medicine is prepared from the following traditional Chinese medicine raw materials in parts by weight: 2-4 parts of radix paeoniae alba, 3-5 parts of cnidium monnieri, 6-8 parts of fructus psoraleae, 7-9 parts of polygonum multiflorum, 5-7 parts of poria cocos, 4-6 parts of black sesame seed, 6-8 parts of dictamnus dasycarpus, 3-5 parts of dahurian angelica root, 4-6 parts of black plum, 7-9 parts of wolfberry, 8-10 parts of gastrodia tuber, 4-6 parts of tribulus terrestris, 5-7 parts of spatholobus stem, 5-8 parts of prepared rehmannia root and 4-6 parts of rhubarb root. The traditional Chinese medicine is prepared from purely-natural traditional Chinese medicines, is used for improving microcirculation of skin, can be used for effectively treating vitiligo, is high in healing speed, is safe and is free of side effect.

Description

One treats leukodermic Chinese medicine
Technical field
The present invention relates to the treatment field of Chinese medicines, is exactly that one treats leukodermic Chinese medicine.
Background technology
Vitiligo is that a kind of common posteriority limit office property or general property skin pigment depigmentation are sick.Melanocyte function due to skin disappears and causes, but mechanism is not clear.The each position of whole body can occur, and is common in and refers to the back of the body, wrist, forearm, face, neck and surrounding genital etc.The many no conscious symptons of primary disease, small number of patients is at premorbid or have local, affected part scratchiness simultaneously.Vitiligo often accompanies other autoimmune diseasees, as diabetes, thyroid disease, adrenal insufficiency etc.
Summary of the invention
The object of this invention is to provide the leukodermic Chinese medicine of a kind for the treatment of evident in efficacy.
The present invention adopts following technical scheme:
One treats leukodermic Chinese medicine, it is characterized in that, it is made up of the raw material of Chinese medicine of following weight proportion: Radix Paeoniae Alba 2-4, Fructus Cnidii 3-5, Fructus Psoraleae 6-8, Radix Polygoni Multiflori 7-9, Poria 5-7, Semen Sesami Nigrum 4-6, Cortex Dictamni 6-8, Radix Angelicae Dahuricae 3-5, Fructus Mume 4-6, Fructus Lycii 7-9, Rhizoma Gastrodiae 8-10, Fructus Atriplicis Sibiricae 4-6, Caulis Spatholobi 5-7, Radix Rehmanniae Preparata 5-8, Radix Et Rhizoma Rhei 4-6.
The leukodermic Chinese medicine of described treatment, is characterized in that: it is made up of the crude drug of following weight portion: the Radix Paeoniae Alba 4, Fructus Cnidii 5, Fructus Psoraleae 7, Radix Polygoni Multiflori 8, Poria 7, Semen Sesami Nigrum 6, Cortex Dictamni 8, the Radix Angelicae Dahuricae 4, Fructus Mume 6, Fructus Lycii 9, Rhizoma Gastrodiae 10, Fructus Atriplicis Sibiricae 6, Caulis Spatholobi 7, Radix Rehmanniae Preparata 8, Radix Et Rhizoma Rhei 6.
Advantage of the present invention is as follows:
The present invention accepts clinic case more than 102 people for medical treatment, and total effective rate reaches 88%, and natural Chinese medicines of the present invention makes, and improves skin microcirculation, effectively can be used for the treatment of vitiligo, and cure rapidly, safety has no side effect.Wherein Fructus Atriplicis Sibiricae has suppressing the hyperactive liver resolving depression, effect of dispelling pathogenic wind for improving eyesight, can be used for the treatment of the diseases such as skin pruritus.
Detailed description of the invention
The leukodermic Chinese medicine of described treatment, it is made up of the crude drug of following weight portion (g): the Radix Paeoniae Alba 4, Fructus Cnidii 5, Fructus Psoraleae 7, Radix Polygoni Multiflori 8, Poria 7, Semen Sesami Nigrum 6, Cortex Dictamni 8, the Radix Angelicae Dahuricae 4, Fructus Mume 6, Fructus Lycii 9, Rhizoma Gastrodiae 10, Fructus Atriplicis Sibiricae 6, Caulis Spatholobi 7, Radix Rehmanniae Preparata 8, Radix Et Rhizoma Rhei 6.
Usage and consumption: take 1 note day, decoct water, divide and take for 2 to 3 times.Within two weeks, be a course for the treatment of, generally take 1-3 the course for the treatment of.

Claims (2)

1. the leukodermic Chinese medicine for the treatment of, it is characterized in that, it is made up of the raw material of Chinese medicine of following weight proportion: Radix Paeoniae Alba 2-4, Fructus Cnidii 3-5, Fructus Psoraleae 6-8, Radix Polygoni Multiflori 7-9, Poria 5-7, Semen Sesami Nigrum 4-6, Cortex Dictamni 6-8, Radix Angelicae Dahuricae 3-5, Fructus Mume 4-6, Fructus Lycii 7-9, Rhizoma Gastrodiae 8-10, Fructus Atriplicis Sibiricae 4-6, Caulis Spatholobi 5-7, Radix Rehmanniae Preparata 5-8, Radix Et Rhizoma Rhei 4-6.
2. the leukodermic Chinese medicine for the treatment of according to claim 1, is characterized in that: it is made up of the crude drug of following weight portion: the Radix Paeoniae Alba 4, Fructus Cnidii 5, Fructus Psoraleae 7, Radix Polygoni Multiflori 8, Poria 7, Semen Sesami Nigrum 6, Cortex Dictamni 8, the Radix Angelicae Dahuricae 4, Fructus Mume 6, Fructus Lycii 9, Rhizoma Gastrodiae 10, Fructus Atriplicis Sibiricae 6, Caulis Spatholobi 7, Radix Rehmanniae Preparata 8, Radix Et Rhizoma Rhei 6.
CN201510284958.2A 2015-05-29 2015-05-29 Traditional Chinese medicine for treating vitiligo Pending CN104840775A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510284958.2A CN104840775A (en) 2015-05-29 2015-05-29 Traditional Chinese medicine for treating vitiligo

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510284958.2A CN104840775A (en) 2015-05-29 2015-05-29 Traditional Chinese medicine for treating vitiligo

Publications (1)

Publication Number Publication Date
CN104840775A true CN104840775A (en) 2015-08-19

Family

ID=53841020

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510284958.2A Pending CN104840775A (en) 2015-05-29 2015-05-29 Traditional Chinese medicine for treating vitiligo

Country Status (1)

Country Link
CN (1) CN104840775A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106421446A (en) * 2016-11-30 2017-02-22 广西壮族自治区都安瑶族自治县科学技术情报研究所 Medicinal liquor for treating leucoderma and preparation method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101637512A (en) * 2009-09-11 2010-02-03 刁保忠 Traditional Chinese medicine preparation for treating vitiligo
CN101744950A (en) * 2008-12-17 2010-06-23 赵双璧 Medicine for treating vitiligo disease and preparation method thereof
CN104474298A (en) * 2014-11-21 2015-04-01 王正琦 Traditional Chinese medicine for treating vitiligo

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101744950A (en) * 2008-12-17 2010-06-23 赵双璧 Medicine for treating vitiligo disease and preparation method thereof
CN101637512A (en) * 2009-09-11 2010-02-03 刁保忠 Traditional Chinese medicine preparation for treating vitiligo
CN104474298A (en) * 2014-11-21 2015-04-01 王正琦 Traditional Chinese medicine for treating vitiligo

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
哈孝贤: "漫谈外阴白癜风及中医的治疗", 《开卷有益(求医问药)》 *
李红毅 等: "《当代中医皮肤科临床家丛书》", 31 October 2014, 中国医药科技出版社 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106421446A (en) * 2016-11-30 2017-02-22 广西壮族自治区都安瑶族自治县科学技术情报研究所 Medicinal liquor for treating leucoderma and preparation method thereof

Similar Documents

Publication Publication Date Title
CN102397413A (en) Traditional Chinese medicine for treating diarrhea
CN103505534B (en) Traditional Chinese medicine composition for treating rheumatic arthralgia
CN104147502A (en) Traditional Chinese medicine composition for treating arthralgia and preparation method of traditional Chinese medicine composition
CN104840775A (en) Traditional Chinese medicine for treating vitiligo
CN104857326A (en) Traditional Chinese medicine for treating leucoderma
CN104398915A (en) Traditional Chinese medicinal composition for chronic eczema
CN105617303A (en) Traditional Chinese medicine for pulmonary tuberculosis
CN103550460A (en) Traditional Chinese medicine formula for treatment of dysmenorrhoea
CN104800391A (en) Traditional Chinese medicine for treating hepatitis
CN104173522A (en) Traditional Chinese medicinal composition for treating skin chloasma
CN103565977A (en) Traditional Chinese medicine composition for treating skin chloasma
CN104258050A (en) Traditional Chinese medicine composition for curing chronic nephritis
CN105148174A (en) Traditional Chinese medicine for treating viral hepatitis
CN106138336A (en) A kind of combination of Chinese medicine treating skin chloasma
CN103041106A (en) Traditional Chinese medicine composition for treating vitiligo
CN104367800A (en) Traditional Chinese medicine composition for treating agranulocytosis
CN103800850A (en) Traditional Chinese medicine formula for treating goiter
CN103007195A (en) Chinese herbal medicine for treating liver diseases
CN104042744A (en) Traditional Chinese medicine composition for treating epiphora induced by wind
CN104367917A (en) Traditional Chinese medicine composition for treating breast distending pain
CN103505678A (en) Chinese medicinal composition for treating breast distending pain
CN104042706A (en) Traditional Chinese medicine composition for treating trigeminal neuralgia
CN104887820A (en) Traditional Chinese medicine for treating hepatitis
CN105194000A (en) Traditional Chinese medicine composition for treating skin chloasma
CN105311347A (en) Traditional Chinese medicine composition for treating skin impetigo

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
EXSB Decision made by sipo to initiate substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20150819